The DART DELIVER-02 Study

NCT07217379 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

HIV (Human Immunodeficiency Virus)

Interventions

DRUG: MGD020
DRUG: MGD014
DRUG: Vorinostat
OTHER: Temporary treatment interruption

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]